文献速递骨软组织肉瘤与黑色素瘤

肢体局部晚期血管肉瘤的隔离肢体灌注:多中心研究

Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study.
PubMed 文献 · Eur J Cancer · 2017-09-15

本多中心研究纳入1991至2016年间39例接受高剂量美法仑联合肿瘤坏死因子α隔离肢体灌注(ILP)的肢体局部晚期血管肉瘤患者,中位随访18个月。ILP后58.9%患者达完全缓解(CR),CR患者中位局部无进展生存期显著长于非CR患者(15.4 vs 7.3个月,p=0.015),中位总生存有获益趋势(81.2 vs 14.5个月,p=0.054)。结论认为ILP是肢体局部晚期血管肉瘤的有效治疗选择。

要点

  • 39例肢体局部晚期血管肉瘤患者接受ILP,58.9%达完全缓解,25.6%部分缓解。
  • CR患者中位局部PFS 15.4个月,非CR患者7.3个月,差异显著(p=0.015)。
  • 中位OS CR组81.2个月 vs 非CR组14.5个月,仅见获益趋势(p=0.054)。

核心结论

  • ILP是肢体局部晚期血管肉瘤的有效治疗选择,可获得高完全缓解率、高保肢率和延长的局部无进展生存期。

研究设计与样本

  • 多中心研究,从三家三级转诊中心前瞻性维护的数据库中识别1991至2016年间接受ILP的肢体血管肉瘤患者,共纳入39例。
  • ILP采用高剂量美法仑联合肿瘤坏死因子α。

主要发现

  • ILP后即刻疗效:23例(58.9%)完全缓解,10例(25.6%)部分缓解,4例(10.3%)疾病稳定,2例(5.1%)疾病进展。
  • 22例(56.4%)出现局部进展,9例(23.1%)出现远处转移。
  • CR患者较非CR患者中位局部无进展生存期显著延长(15.4 vs 7.3个月,p=0.015)。
  • CR患者较非CR患者中位总生存有获益趋势(81.2 vs 14.5个月,p=0.054)。
  • 6例接受多次ILP,第1、2、3次ILP的CR率分别为60%、80%、67%。

临床怎么用

  • 对于肢体局部晚期血管肉瘤,ILP可作为治疗选择之一,以争取高完全缓解率和保肢。
  • ILP后达CR的患者局部无进展生存期更长,中位总生存有获益趋势。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Angiosarcomas are rare and aggressive soft-tissue sarcomas. The only potential curative treatment is complete surgical excision. This study reports the outcome of isolated limb perfusion (ILP) with high-dose melphalan and tumour necrosis factor α for locally advanced angiosarcoma. MATERIAL AND METHODS: All patients who underwent an ILP for angiosarcomas between 1991 and 2016 in three tertiary referral centres were identified from prospectively maintained databases. RESULTS: A total of 39 patients were included, with a median follow-up of 18 months (interquartile range 6.1-60.8). Of these patients, 23 (58.9%) patients had a complete response (CR) after ILP, 10 (25.6%) had a partial response, 4 (10.3%) had stable disease and 2 (5.1%) patients had progressive disease immediately after ILP. A total of 22 patients developed local progression (56.4%), whereas nine (23.1%) developed distant metastases. The patients with CR had a significantly prolonged median local progression-free survival (PFS) (15.4 versus 7.3 months, p = 0.015) when compared with non-CR patients, and a trend towards better median overall survival (81.2 versus 14.5 months, p = 0.054). Six patients underwent multiple ILPs, whereby the CR rate of the first, second and third ILPs were 60%, 80% and 67%, respectively. Thirteen (33.3%) patients needed further surgical intervention, consisting of resection in eight patients (20.5%) and amputation in five patients (12.8%). CONCLUSION: ILP is an effective treatment option for patients with locally advanced angiosarcoma in the extremities, resulting in a high number of CRs, a high limb salvage rate and prolonged local PFS.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Huis In 't Veld EA, Grünhagen DJ, Verhoef C, et al. Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study. Eur J Cancer. 2017. PMID: 28918185. doi:10.1016/j.ejca.2017.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。